Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DE LA SORBONNE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE LA SORBONNE is a French company
founded 15 years ago,
specialized in the sector Gestion de fonds.
Based in ALFORTVILLE (94140),
this company of category PME
shows in 2024 a net income positive of 73 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE LA SORBONNE (SIREN 524291663)
Indicator
2024
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
73 441 €
220 285 €
253 923 €
50 395 €
68 843 €
40 281 €
23 669 €
65 366 €
49 908 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE DE LA SORBONNE generates positive net income of 73 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 50 k€ -> 73 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
73 441 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 99%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.039%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
98.706%
Solvency indicators evolution SELARL PHARMACIE DE LA SORBONNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2024
Debt ratio
169.104
115.719
95.419
67.718
43.378
48.278
14.701
1.03
0.039
Financial autonomy
32.8
40.454
43.199
52.393
61.194
61.73
72.453
90.257
98.706
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
0.042024
2021
2022
2024
Q1: 0.0
Med: 8.28
Q3: 92.71
Good-22 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE DE LA SO... (0.04) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
98.71%2024
2021
2022
2024
Q1: 4.63%
Med: 48.43%
Q3: 87.31%
Excellent+11 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DE LA SO... (98.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 7965.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
7965.676
Liquidity indicators evolution SELARL PHARMACIE DE LA SORBONNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2024
Liquidity ratio
163.549
172.071
132.496
133.344
146.663
318.313
262.122
527.821
7965.676
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
7965.682024
2021
2022
2024
Q1: 100.71
Med: 472.45
Q3: 3122.85
Excellent+34 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE DE LA SO... (7965.68) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELARL PHARMACIE DE LA SORBONNE in its sector
Comparison with sector Gestion de fonds
Valuation estimate
Based on 62 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DE LA SORBONNE is estimated at
542 821 €
(range 154 121€ - 1 075 386€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
62 tx
154k€542k€1075k€
542 821 €Range: 154 121€ - 1 075 386€
NAF 5 année 2024
Valuation method used
Net Income Multiple
73 441 €
×
7.4x
=542 821 €
Range: 154 121€ - 1 075 387€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Gestion de fonds)
Compare SELARL PHARMACIE DE LA SORBONNE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE LA SORBONNE
What is the revenue of SELARL PHARMACIE DE LA SORBONNE ?
The revenue of SELARL PHARMACIE DE LA SORBONNE is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DE LA SORBONNE profitable?
Yes, SELARL PHARMACIE DE LA SORBONNE generated a net profit of 73 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DE LA SORBONNE ?
The headquarters of SELARL PHARMACIE DE LA SORBONNE is located in ALFORTVILLE (94140), in the department Val-de-Marne.
Where to find the tax return of SELARL PHARMACIE DE LA SORBONNE ?
The tax return of SELARL PHARMACIE DE LA SORBONNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE LA SORBONNE operate?
SELARL PHARMACIE DE LA SORBONNE operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart